NCT05513677 (PRO30CSP) is a NA clinical trial of M4D in Urinary Tract Infections, sponsored by Camstent Ltd..

Who is sponsoring NCT05513677?

NCT05513677 is sponsored by Camstent Ltd..

What drugs are being tested in NCT05513677?

Interventions in NCT05513677: M4D, Standard of Care.

What condition does NCT05513677 study?

NCT05513677 studies Urinary Tract Infections.

Is NCT05513677 still recruiting?

NCT05513677 is currently completed. Last updated 31 August 2022.

Last reviewed 2022-08-31 · How we verify

NCT05513677: PRO30CSP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Characterisation of Biofilm Growth on Coated vs. Uncoated Urinary Catheter Surfaces in Normal Clinical Use

Completed NA Last updated 31 August 2022

What this trial tests

NA trial testing M4D in Urinary Tract Infections in 35 participants. Completed in 30 December 2021.

Timeline

14 August 2018

Primary endpoint
20 May 2020

30 December 2021

Quick facts

Lead sponsor	Camstent Ltd.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	other
Enrollment	35
Start date	14 August 2018
Primary completion	20 May 2020
Estimated completion	30 December 2021
Sites	1 location across United Kingdom

Drugs / interventions tested

M4D
Standard of Care

Conditions studied

Urinary Tract Infections — all drugs for Urinary Tract Infections →

Sponsor

Camstent Ltd.

Who can join

18 and older, any sex, with Urinary Tract Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. Evaluated Patients: 5 patients (Convenience sample: non-blinded, non-randomised) Selection follows documented hospital protocols for routine catheterisation 2. Measured Patients: 30 patients (Convenience sample: non-blinded and non-randomised) * 20 who receive the M4D coated catheter. * 10 who receive the standard uncoated catheters used in routine patient care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Urinary Tract Infections

Currently open trials in the same condition.

NCT06976125 — Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulat · NA · recruiting
NCT06808451 — Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture · NA · recruiting
NCT07186465 — Microbiome-Modulating Prophylaxis RCT: Antibiotic vs Gynoflor in Postmenopausal Women With Recurrent Cystitis · Phase 4 · recruiting
NCT07207291 — Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers · Phase 1 · recruiting
NCT06715306 — Intravenous Versus Oral Treatment of the Main Acute Infections · NA · recruiting

Other Camstent Ltd. trials

Trials by the same sponsor.

NCT05719753 — The Effectiveness of a Bacteriophobic Coating on Urinary Catheters · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05513677 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Camstent Ltd.
Last refreshed: 31 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05513677.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing